Indications and uses
temporarily relieves minor aches and pains due to: headache toothache backache menstrual cramps the common cold muscular aches minor pain of arthritis temporarily reduces fever
Advil - Haleon US Holdings LLC
- Manufacturer
- Haleon US Holdings LLC
- Effective date
- 2026-07-29
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 37
- Source
- daily-update
- Hydrated at
- 2026-08-01 05:10:13
Label at a glance#
ProductAdvil
Active ingredientIBUPROFEN
Label structure13 sections
Dosage and administration
do not take more than directed the smallest effective dose should be used adults and children 12 years and over: take 1 capsule every 4 to 6 hours while symptoms persist if pain or fever does not respond to 1 capsule, 2 capsules may be used do not exceed 6 capsules in 24 hours, unless directed by a doctor children under 12 years: ask a doctor
Contacts and useful links#
Label contents#
Full prescribing information#
Active ingredient (in each capsule)
Solubilized ibuprofen equal to 200 mg ibuprofen (NSAID)*
(present as the free acid and potassium salt)
*nonsteroidal anti-inflammatory drug
Purpose
Pain reliever/Fever reducer
Uses
- temporarily relieves minor aches and pains due to:
- headache
- toothache
- backache
- menstrual cramps
- the common cold
- muscular aches
- minor pain of arthritis
- temporarily reduces fever
Warnings
Allergy alert:
Ibuprofen may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
- hives
- facial swelling
- asthma (wheezing)
- shock
- skin reddening
- rash
- blisters
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning:
This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you
- are age 60 or older
- have had stomach ulcers or bleeding problems
- take a blood thinning (anticoagulant) or steroid drug
- take other drugs containing prescription or nonprescription NSAIDs [aspirin, ibuprofen, naproxen, or others]
- have 3 or more alcoholic drinks every day while using this product
- take more or for a longer time than directed
Heart attack and stroke warning:
NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
Do not use
- if you have ever had an allergic reaction to any other pain reliever/fever reducer
- right before or after heart surgery
Ask a doctor before use if
- stomach bleeding warning applies to you
- you have problems or serious side effects from taking pain relievers or fever reducers
- you have a history of stomach problems, such as heartburn
- you have high blood pressure, heart disease, liver cirrhosis, kidney disease, asthma, or had a stroke
- you are taking a diuretic
Ask a doctor or pharmacist before use if you are
- under a doctor's care for any serious condition
- taking aspirin for heart attack or stroke, because ibuprofen may decrease this benefit of aspirin
- taking any other drug
When using this product
- take with food or milk if stomach upset occurs
Stop use and ask a doctor if
- you experience any of the following signs of stomach bleeding:
- feel faint
- vomit blood
- have bloody or black stools
- have stomach pain that does not get better
- you have symptoms of heart problems or stroke:
- chest pain
- trouble breathing
- weakness in one part or side of body
- slurred speech
- leg swelling
- pain gets worse or lasts more than 10 days
- fever gets worse or lasts more than 3 days
- redness or swelling is present in the painful area
- any new symptoms appear
If pregnant or breast-feeding,
ask a health professional before use. It is especially important not to use ibuprofen at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
Keep out of reach of children.
In case of overdose, get medical help or contact a Poison Control Center right away.
Directions
- do not take more than directed
- the smallest effective dose should be used
- adults and children 12 years and over: take 1 capsule every 4 to 6 hours while symptoms persist
- if pain or fever does not respond to 1 capsule, 2 capsules may be used
- do not exceed 6 capsules in 24 hours, unless directed by a doctor
- children under 12 years: ask a doctor
Other information
- each capsule contains: potassium 20 mg
- read all warnings and directions before use. Keep carton.
- store at 20-25°C (68-77°F)
- avoid excessive heat above 40°C (104°F)
Inactive ingredients
Advil Liqui-Gels
FD&C green no. 3, gelatin, lecithin (soybean), medium-chain triglycerides, pharmaceutical ink, polyethylene glycol, potassium hydroxide, purified water, sorbitol sorbitan solution
Advil Liqui-Gels Minis
FD&C green no. 3, gelatin, medium-chain triglycerides, pharmaceutical ink, polyethylene glycol, potassium hydroxide, purified water, sorbitol sorbitan solution
Questions or comments?– Advil Liqui-Gels and Liqui-Gel Minis
call toll free 1-855-297-3031
Questionsor comments?- Easy Open Arthritis Bottle
call toll free 1-800-88-ADVIL
Additional Information
Do Not Use if seal under bottle cap imprinted with “SEALED for YOUR PROTECTION”is broken or missing.
PRINCIPAL DISPLAY PANEL
Advil
®
LIQUI•GELS®
Solubilized Ibuprofen Capsules, 200 mg
Pain Reliever/Fever Reducer
(NSAID)
Actual Size
20
Liquid Filled
Capsules
PRINCIPAL DISPLAY PANEL- 160 Capsule Bottle Label
- Easy OpenARTHRITIS CAP
EASE OF USECERTIFIED
Arthritis Foundation
Advil
Liqui-Gels®
Solubilized Ibuprofen Capsules, 200 mg
Pain Reliever/Fever Reducer
(NSAID)
THIS PACKAGE FOR HOUSEHOLDS WITHOUT YOUNG CHILDREN
Actual Size
160
Liquid Filled
Capsules
PRINCIPAL DISPLAY PANEL
SmallerCapsule
SameStrength*
Advil
®
LIQUI•GELS®
minis
Solubilized Ibuprofen Capsules, 200 mg
Pain Reliever/Fever Reducer
(NSAID)
*Compared to Advil ®Liqui-Gels ®
Actual Size
20
Liquid Filled
Capsules
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 1e73f975-1ce7-705e-2bcf-788b1b5e24ba | Product name | 5 | 20251124 |
| 16cde546-8deb-4df2-a072-dab5566ede95 | Product name | 1 | 20231003 |
| f6d1b8d7-3bd1-4248-eddd-b60565c88015 | Product name | 4 | 20230808 |
| 874f4e63-49d2-5150-5d77-052172814ebd | Product name | 6 | 20230105 |
| 557673c2-8256-b351-e863-4ec71a5a64b0 | Product name | 2 | 20160714 |
| dbc9a339-6215-4e94-9546-57a3b34902ce | Product name | 1 | 20160517 |
| 6084a4f4-5437-c9a5-caec-5361ee075a59 | Product name | 1 | 20140508 |
| 61c18d4e-b552-5478-8fc0-df38b93e3100 | Product name | 1 | 20140508 |
| 7b2938c9-7eb7-e312-ae90-f54f4240361e | Product name | 1 | 20140508 |
| 90c5639a-61b0-88d6-ddcf-21888e94869a | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| 997601aa-bb5f-6971-6b90-a21132c12c7b | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Billing Units#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| IBUPROFEN | ACTIVE INGREDIENT | WK2XYI10QM | 10 | |
| IBUPROFEN | ACTIVE MOIETY | WK2XYI10QM | 10 | |
| COCONUT OIL | INACTIVE INGREDIENT | Q9L0O73W7L | 10 | |
| FD&C GREEN NO. 3 | INACTIVE INGREDIENT | 3P3ONR6O1S | 10 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | 10 | |
| LECITHIN, SOYBEAN | INACTIVE INGREDIENT | 1DI56QDM62 | 10 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 10 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | 10 | |
| SORBITAN | INACTIVE INGREDIENT | 6O92ICV9RU | 10 | |
| SORBITOL | INACTIVE INGREDIENT | 506T60A25R | 10 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 10 |
Products#
Every source-derived product name is available through these pages.
- Advil
- ibuprofen
- FD&C GREEN NO. 3
- GELATIN, UNSPECIFIED
- SOYBEAN LECITHIN
- MEDIUM-CHAIN TRIGLYCERIDES
- POLYETHYLENE GLYCOL, UNSPECIFIED
- POTASSIUM HYDROXIDE
- WATER
- SORBITAN
- SORBITOL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 0573-0169 | 0573-0169-17, 0573-0169-02, 0573-0169-19, 0573-0169-20, 0573-0169-40, 0573-0169-11, 0573-0169-89, 0573-0169-30, 0573-0169-31, 0573-0169-86, 0573-0169-51, 0573-0169-43, 0573-0169-49, 0573-0169-52, 0573-0169-08, 0573-0169-22, 0573-0169-13, 0573-0169-76, 0573-0169-16 |
| 0573-0149 | 0573-0149-13, 0573-0149-04, 0573-0149-66, 0573-0149-91 |
| 0573-1769 | 0573-1769-20, 0573-1769-80, 0573-1769-89, 0573-1769-14, 0573-1769-13, 0573-1769-09, 0573-1769-02, 0573-1769-87, 0573-1769-16, 0573-1769-31, 0573-1769-92 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 36 | 2025-07-10 | full-release | 2026-06-01 01:06:54 |
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | POWDER, FOR SUSPENSION / ORAL | 39 mg | ||
| SORBITAN | SORBITAN | 6O92ICV9RU | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| FD&C GREEN NO. 3 | FD&C GREEN NO. 3 | 3P3ONR6O1S | CAPSULE, LIQUID FILLED / ORAL | 0.03 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | POWDER, FOR SUSPENSION / ORAL | 39 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | LIQUID / ORAL | 53460 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| FD&C GREEN NO. 3 | FD&C GREEN NO. 3 | 3P3ONR6O1S | CAPSULE, LIQUID FILLED / ORAL | 0.03 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, LIQUID FILLED / ORAL | 1042 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION / ORAL | 29268 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| GELATIN | GELATIN | 2G86QN327L | CAPSULE, LIQUID FILLED / ORAL | 1042 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SUSPENSION / ORAL | 45000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER / ORAL | 36000 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, LIQUID FILLED / ORAL | 154 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, EXTENDED RELEASE / ORAL | 428 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg | ||
| COCONUT OIL | COCONUT OIL | Q9L0O73W7L | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, COATED / ORAL | 12.96 mg | ||
| FD&C GREEN NO. 3 | FD&C GREEN NO. 3 | 3P3ONR6O1S | CAPSULE, LIQUID FILLED / ORAL | 0.03 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| POTASSIUM HYDROXIDE | POTASSIUM HYDROXIDE | WZH3C48M4T | CAPSULE, LIQUID FILLED / ORAL | 154 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET / ORAL | 337.28 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, FILM COATED / ORAL | 0.33 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION, CONCENTRATE / ORAL | 300 mg/1ml | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, FILM COATED / ORAL | 0.33 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | GUM, CHEWING / ORAL | 6168 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CAPSULE / ORAL | 1111 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| SORBITAN | SORBITAN | 6O92ICV9RU | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| SORBITOL | SORBITOL | 506T60A25R | POWDER, FOR SUSPENSION / ORAL | 12000 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION, CONCENTRATE / ORAL | 300 mg/1ml | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, FILM COATED / ORAL | 5 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET / ORAL | 8 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | CONCENTRATE / ORAL | 600 mg/1ml | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, FILM COATED / ORAL | 0.33 mg | ||
| SORBITAN | SORBITAN | 6O92ICV9RU | CAPSULE, LIQUID FILLED / ORAL | NA | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | TABLET, EXTENDED RELEASE / ORAL | 20 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | ELIXIR / ORAL | 833.3 mg | ||
| FD&C GREEN NO. 3 | FD&C GREEN NO. 3 | 3P3ONR6O1S | CAPSULE, LIQUID FILLED / ORAL | 0.03 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| FD&C GREEN NO. 3 | FD&C GREEN NO. 3 | 3P3ONR6O1S | CAPSULE, LIQUID FILLED / ORAL | 0.03 mg | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, ORALLY DISINTEGRATING / ORAL | 7 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | SOLUTION, CONCENTRATE / ORAL | 300 mg/1ml | ||
| LECITHIN, SOYBEAN | SOYBEAN LECITHIN | 1DI56QDM62 | CAPSULE / ORAL | 20 mg | ||
| SORBITOL | SORBITOL | 506T60A25R | TABLET, CHEWABLE / ORAL | 3555 mg |
Orange Book application contexts#
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020402-001 | ADVIL LIQUI-GELS | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | |
| N020402-002 | ADVIL MIGRAINE LIQUI-GELS | IBUPROFEN | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-15 13:18:30 | 2026-09 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 8072bd15b7f6… | |
| 2024-05-31 18:47 UTC | 2024-05 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5c6f7cd8ea54… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 5d02ea3f76ae… | |
| 2022-04-08 23:34 UTC | 2022-04 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020402-001 | ADVIL LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 1995-04-20 | 4b0b4de00fa7… | |
| 2022-04-04 05:41 UTC | 2022-04 | N020402-002 | ADVIL MIGRAINE LIQUI-GELS | EQ 200MG FREE ACID AND POTASSIUM SALT | CAPSULE / ORAL | RLD, RS | 2000-03-16 | 4b0b4de00fa7… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.